Many studies show that commercial money influences researchers to sway clinical trial results in favour of the drug or device they are testing – eg, a study funded by a drug company claimed that antidepressants were better than talking therapy. The US has the 2010 Physician Payments Sunshine Act for transparency – the UK has no such law.


